Home
AnnouncementsNIH Funding AnnouncementsActive Funding Announcements and Information
Active Funding Announcements and Information
Active Funding Opportunity Announcements
- PAR-13-115 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21) (NIH, ORIP, NHLBI, NIAMS, NIDCR)
- PAR-13-114 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01) (NIH, ORIP, NHLBI, NIDCR, NIAMS, NIDDK, NIGMS)
- PAR-13-113 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24) (NIH, ORIP)
- NOT-AR-13-013 Notice of NIAMS' Participation in PAR-13-114 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01) (NIAMS)
- NOT-AR-13-014 Notice of NIAMS' Participation in PAR-13-115 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21) (NIAMS)
- RFA-DC-13-002 Innovative and Novel Approaches toward Inner Ear Regenerative Therapies by Early Stage Investigators (R01) (NIDCD)
- PAR-13-095 Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R21) (NICHD)
- PAR-13-094 Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R01) (NICHD)
- PAR-11-107Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01) (NIDDK)
- PA-12-232 Stem Cells and Alcohol-induced Tissue Injuries (R21) (NIAAA)
- PA-12-233 Stem Cells and Alcohol-induced Tissue Injuries (R01) (NIAAA)
- PA-09-248 Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (R21) (NHLBI)
- RFA-EY-12-001 Stem Cell Approaches to Developing New Therapies for Ocular Diseases (R01) (NEI)
- NOT-RM-12-007 Pre-Application Teleconference for RFA-RM-11-022 Integrated Microphysiological Systems for Drug Efficacy and Toxicity Testing in Human Health and Disease (UH2/UH3) and RFA-RM-12-001 Stem/Progenitor Cell-Derived Human Micro-organs and -tissues (U18) (NIH)
- RFA-RM-11-013 Studies to Evaluate Cellular Heterogeneity Using Transcriptional Profiling of Single Cells (U01) (NIH)
- RFA-RM-11-014 Exceptionally Innovative Tools and Technologies for Single Cell Analysis (R21) (NIH)
- RFA-RM-11-015 Accelerating the Integration and Translation of Technologies to Characterize Biological Processes at the Single Cell Level (R01) (NIH)
- RFA-RM-11-022 Integrated Microphysiological Systems for Drug Efficacy and Toxicity Testing in Human Health and Disease (UH2/UH3) (NIH)
- RFA-RM-12-001 Stem/Progenitor Cell-Derived Human Micro-organs and -tissues (U18) (NIH)
- RFA-ES-11-010 Environmental Influences on Stem Cells in Development, Health, and Disease (R21) (NIEHS, NCRR)
- NOT-CA-12-004 NCI Will Participate in RFA-ES-11-010, Environmental Influences on Stem Cells in Development, Health and Disease (R21) (NCI)
- RFA-ES-11-011 Environmental Influences on Stem Cells in Development, Health, and Disease (R01) (NIEHS, NCRR, NICHD)
- RFA-AG-12-008 Human Cell Reprogramming for Aging and Alzheimer's Disease Research (R21) (NIA)
- PA-11-186 Translation of Pluripotent Stem Cell Therapies for Blood Diseases (R01) (NHLBI)
- PAR-11-107 Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01) (NIDDK)
- PA-09-248 Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (R21) (NHLBI)
- PA-09-249 Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (SBIR [R43/R44]) (NHLBI)
- PA-09-250 Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (STTR [R41/R42]) (NHLBI)
- PA-09-110 Career Enhancement Award for Stem Cell Research (K18) (NHLBI, NCI, NIAAA, NIDDK, NIEHS)
Grants Policy Statements
Requests for Information